Abstract
Objective:
To find out whether there is considerable influence on second trimester serum concentrations owing to the rhesus status.
Study design:
This retrospective cohort study was performed at the Perinatology Unit of the GATA Haydarpasa Teaching Hospital. During the study interval, 2265 pregnancies met inclusion criteria. The blood samples were collected in 117 pregnancies with a maternal rhesus-negative blood group status. The control group consisted of 2148 pregnancies with a maternal rhesus-positive blood group status. Statistical analysis was performed by SPSS 11.0 statistical software.
Results:
Pregnancies with a maternal rhesus-negative blood group status were identified in 117 patients. The overall prevalence of pregnancies with a maternal rhesus-negative blood group status were 5.1% in our study. Only unconjugated estriol multiples of the median values were significantly decreased in rhesus-negative women (P<0.001). Alpha-fetoprotein and human chorionic gonadotrophin multiples of the median values did not differ significantly (P>0.05).
Conclusion:
We conclude that if second trimester screening test to be used in Rh negative pregnancies, either the corrected value should be referred or double test result should be considered ignoring the unconjugated estriol result. Another option is the first trimester Down syndrome screening test.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others
References
Merkatz IR, Nitowsky HM, Macri JN, Johnson WE . An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol 1984; 148: 886–894.
Cuckle HS, Wald NJ, Lindenbaum RH . Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome. Lancet 1984; 1: 926–929.
Canick JA, Palomaki GE, Osthanondh R . Prenatal screening for trisomy 18 in the second trimester. Prenat Diagn 1990; 10: 546–548.
Bogart MH, Pandian MR, Jones OW . Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn 1987; 7: 623–630.
Palomaki GE, Knight GJ, Haddow JE, Canick JA, Saller DN, Panizza DS . Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alphafetoprotein, unconjugated oestriol and human chorionic gonadotropin. Prenat Diagn 1992; 12: 925–930.
Palomaki GE, Haddow JE, Knight GJ, Wald NJ, Kennard A, Canick JA et al. Risk-based prenatal screening for trisomy 18 using alphafetoprotein, unconjugated oestriol and human chorionic gonadotropin. Prenat Diagn 1995; 15: 713–723.
Bartels I, Hoppe-Sievert B, Bockel B, Herold S, Caesar J . Adjustment formulae for maternal serum alphafetoprotein, human chorionic gonadotropin, and unconjugated oestriol to maternal weigth and smoking. Prenat Diagn 1993; 13: 123–130.
Crandall BF, Lebherz TB, Schroth PC, Matsumoto M . Alphafetoprotein concentrations in maternal serum: relation to race and body weight. Clin Chem 1983; 29 (3): 531–533.
Wald N, Cuckle H, Wu T, George L . Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome. Br J Obstet Gynaecol 1991; 98: 905–908.
Wald NJ, Cuckle H, Boreham J, Stirrat GM, Turnbull AC . Maternal serum alpha-fetoprotein and diabetes mellitus. Br J Obstet Gynaecol 1979; 86: 101–105.
Daniel DG, Reynolds T, Penney MD . Calculation of Down's syndrome risk. Lancet 1994; 343: 490.
Zimmermann R, Streicher A, Huch R, Huch A . Effect of gravidity and parity on the parameters used in serum screening for trisomy 21. Prenat Diagn 1995; 15: 781–782.
Pepe GJ, Albrecht ED . Actions of placental and fetal adrenal steroid hormones in primate pregnancy. Endocr Rev 1995; 16: 608–648.
Santolaya-Forgas J, Jessup J, Burd LI, Prins GS, Burton BK . Pregnancy outcome in women with low midtrimester maternal serum unconjugated oestriol. J Reprod Med 1996; 41: 87–90.
Kowalczyk TD, Cabaniss ML, Cusmano L . Association of low unconjugated oestriol in the second trimester and adverse pregnancy outcome. Obstet Gynecol 1998; 91: 396–400.
Benn PA, Craffey A, Horne D, Ramsdell L, Rodis JF . Elevated maternal serum alpha-fetoprotein with low unconjugated oestriol and the risk for lethal perinatal outcome. J Matern Fetal Med 2000; 9: 165–169.
Schleifer RA, Bradley LA, Richards DS, Ponting NR . Pregnancy outcome for women with low levels of maternalserum unconjugated oestriol on second-trimester screening. Am J Obstet Gynecol 1995; 173: 1152–1156.
Pasqualini JR, Kind FA . Hormone production and concentration during pregnancy in humans and in other mammalian species. In: Pasqualini JR (ed), Hormones and the Fetus. Pergamon Press: Oxford, 1985, pp 173–333.
Zbella EA, Ilekis J, Scommegna A, Benveniste R . Competitive studies with dehydroepiandrosterone sulphate and 16 alphahydroxydehydroepiandrosterone sulphate in cultured human choriocarcinoma JEG-3 cells: effect on estrone, 17 beta-estradiol, and estriol secretion. J Clin Endocrinol Metab 1986; 63: 751–757.
Sancken U, Bartels I . Preliminary data on an association between blood groups and serum markers used for the so-called ‘triple screening’: free oestriol MoM values are decreased in rhesus-negative (Rhx) women. Prenat Diagn 2001; 21: 194–195.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Muhcu, M., Mungen, E., Dundar, O. et al. Reliability of second trimester triple screening for Down syndrome in rhesus-negative women. J Perinatol 27, 268–271 (2007). https://doi.org/10.1038/sj.jp.7211681
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.jp.7211681


